Interestingly, persistent activation of the IL-6 signalling pathway might result in the development of liver tumors26,46 and RANTES or CCL5 are overexpressed in chronic liver disease and implicated in tumor initiation and progression especially in HCC47. The gene discussed is CCL5; the disease is neoplasm.